1. Regulation of PD-L1 Expression by Nuclear Receptors
   Yoshimitsu Kiriyama et al, 2023, IJMS CrossRef
2. Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
   Lei Liu et al, 2023, Front. Immunol. CrossRef
3. FXR agonist GW4064 enhances anti-PD-L1 immunotherapy in colorectal cancer
   Lu Lu et al, 2023, OncoImmunology CrossRef